当前位置:首页 - 行情中心 - 宣泰医药(688247) - 财务分析 - 现金流量表

宣泰医药

(688247)

  

流通市值:31.46亿  总市值:31.46亿
流通股本:4.53亿   总股本:4.53亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金352,499,429.73247,311,067.48119,281,470.42503,656,812.62
  收到的税费返还2,159,874.321,123,790.67187,542.18,246,043.05
  收到其他与经营活动有关的现金12,044,612.5211,094,635.62,043,594.3413,485,315.35
  经营活动现金流入小计366,703,916.57259,529,493.75121,512,606.86525,388,171.02
  购买商品、接受劳务支付的现金154,706,933.7895,448,732.9541,393,452.64239,801,571.84
  支付给职工以及为职工支付的现金72,875,517.0248,353,898.1426,231,261.12104,696,238.88
  支付的各项税费11,778,814.828,941,010.734,707,657.728,254,774.19
  支付其他与经营活动有关的现金39,185,467.121,737,970.329,002,876.7157,309,727.8
  经营活动现金流出小计278,546,732.72174,481,612.1481,335,248.17430,062,312.71
  经营活动产生的现金流量净额88,157,183.8585,047,881.6140,177,358.6995,325,858.31
二、投资活动产生的现金流量:
  收回投资收到的现金738,000,000404,000,000165,000,0001,962,000,000
  取得投资收益收到的现金6,402,040.042,857,527.711,248,724.659,636,920.89
  投资活动现金流入小计744,402,040.04406,857,527.71166,248,724.651,971,636,920.89
  购建固定资产、无形资产和其他长期资产支付的现金16,964,940.3914,002,390.097,349,996.3941,558,417.09
  投资支付的现金1,128,500,000720,000,000460,000,0001,813,100,000
  投资活动现金流出小计1,145,464,940.39734,002,390.09467,349,996.391,854,658,417.09
  投资活动产生的现金流量净额-401,062,900.35-327,144,862.38-301,101,271.74116,978,503.8
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金6,250,985.666,250,985.66-27,838,140.03
  支付其他与筹资活动有关的现金51,083.7633,868.7216,840.868,298.8
  筹资活动现金流出小计6,302,069.426,284,854.3816,840.827,906,438.83
  筹资活动产生的现金流量净额-6,302,069.42-6,284,854.38-16,840.8-27,906,438.83
四、汇率变动对现金及现金等价物的影响-3,906,455.87-3,105,796.08-2,069,984.25-3,294,230.88
五、现金及现金等价物净增加额-323,114,241.79-251,487,631.23-263,010,738.1181,103,692.4
  加:期初现金及现金等价物余额406,889,473.83406,889,473.83406,889,473.83225,785,781.43
  期末现金及现金等价物余额83,775,232.04155,401,842.6143,878,735.73406,889,473.83
补充资料:
  净利润-29,701,777.95-47,482,814.69
  资产减值准备-891,116.42-17,539,733.26
  固定资产和投资性房地产折旧-13,752,851.48-25,102,090.17
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-13,752,851.48-25,102,090.17
  无形资产摊销-3,341,621.06-6,729,811.12
  长期待摊费用摊销-167,938.33-494,046.58
  递延收益摊销--4,377,831.04--
  固定资产报废损失-172.27-363,521.15
  公允价值变动损失----1,341,275.35
  财务费用-3,073,573-3,274,781.43
  投资损失--7,814,596.51--9,294,077.87
  递延所得税-470,979.7-173,175.03
  其中:递延所得税资产减少-540,012.37-318,487.85
    递延所得税负债增加--69,032.67--145,312.82
  存货的减少--5,185,415.61-14,434,028.17
  经营性应收项目的减少-31,500,759.8-22,885,324.76
  经营性应付项目的增加-20,742,352--17,747,726.24
  其他-1,739,160.39--16,290,725.38
  现金的期末余额-155,401,842.6-406,889,473.83
  减:现金的期初余额-406,889,473.83-225,785,781.43
  现金及现金等价物的净增加额--251,487,631.23-181,103,692.4
公告日期2026-10-292026-08-282026-04-302026-04-30
审计意见(境内)标准无保留意见
TOP↑